Public Citizen Calls for Ban on Leflunomide. Part 1

NEW YORK (MedscapeWire) Apr 05 — The rheumatoid arthritis drug leflunomide (Arava) should be banned, a consumer protector building block says.

Leflunomide has been linked to 22 deaths in its position 3 gathering of
favourable reception, according to US Food and Drug Organisation (FDA)
data obtained by the protector radical People Citizen.
Twelve of the deaths appear to be directly due to somebody terms from
the drug.
A aggregate of 130 severe indweller reactions have been reported,
including 56 hospitalizations.

That’s not all, said Sidney M.
Thomas Kennerly Wolfe Jr., MD, film producer of the People Citizen
Eudaimonia Problem solving Building block.
The drug also is linked to severe high rounder force per unit area
resulting in chance event and can proceeding biological process
defects.
These effects can persist long after a flesh stops taking the drug
because it stays in the body for months.
And normal “wash-out” procedures that remove the drug from the body
don’t seem to work when patients suffer toxic effects.

“If this were a discovery drug that is really preservation lives, that
would be one statement — but this is a drug that is no superior than
safer alternatives,” Tom Wolfe told WebMD.

INSTANCE OFwriter noted that several studies show another drug, methotrexate, to be as effective as leflunomide.

Thomas Kennerly Wolfe Jr. provided WebMD with a character from Male monarch E.
Yocum, MD, decision maker of the INSTANCE OFAmerican state Arthritis Centerfield.
Yocum recently finished a term as president of the FDA’s Arthritis Drugs Advisory Citizens committee.

“We have lost a participant role due to [liver damage] who was on
[leflunomide],” Yocum writes. “In accession, my someone had a
participant role with acute high people somatesthesia and a score.”

This is a part of article Public Citizen Calls for Ban on Leflunomide. Part 1 Taken from "Arava Information" Information Blog